Additionally, given interest in other potential markers of inflammation in relation to depression treatment response, we also explored relationships between several other inflammatory markers including CRP, IL-6, IL-10, TNF-α, and ketamine treatment outcome. This evidence concerns the gene IL10 and depressive symptom measurement.